SEER data: Perspective at 10,000 feet

Gynecologic Oncology

Volumn 110, Issue 2, 2008, Pages 121-122

  Gershenson, David M ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER EPIDEMIOLOGY; CANCER STAGING; CANCER SURVIVAL; EDITORIAL; GYNECOLOGIC SURGERY; HUMAN; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MALIGNANT OVARIAN GERM CELL TUMOR; OVARY CANCER; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

DATABASES, FACTUAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; OVARIAN NEOPLASMS; SEER PROGRAM; UNITED STATES;

EID: 47249113494     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2008.06.019     Document Type: Editorial

References (15)

1. Gershenson D.M., Morris M., Cangir A., Kavanagh J.J., Stringer C.A., Edwards C.L., et al. Treatment of malignant germ cell tumors of the ovary with bleomycin, etoposide, and cisplatin. J. Clin. Oncol. 8 (1990) 715-720
2. Williams S., Blessing J.A., Liao S.Y., Ball H., and Hanjani P. Adjuvant therapy of ovarian germ cell tumors with cisplatin, etoposide, and bleomycin: a trial of the Gynecologic Oncology Group. J. Clin. Oncol. 12 (1994) 701-706
3. Bonazzi C., Peccatori F., Colombo N., Lucchini V., Cantu M.G., and Mangioni C. Pure ovarian immature teratoma, a unique and curable disease: 10 years' experience of 32 prospectively treated patients. Obstet. Gynecol. 84 (1994) 598-604
4. Cushing B., Giller R., Ablin A., Cohen L., Cullen J., Hawkins E., et al. Surgical resection alone is effective treatment for ovarian immature teratoma in children and adolescents: a report of the pediatric oncology group and the children's cancer group. Am. J. Obstet. Gynecol. 181 (1999) 353-358
5. Marina N.M., Cushing B., Giller R., Cohen L., Lauer S.J., Ablin A., et al. Complete surgical excision is effective treatment for children with immature teratomas with or without malignant elements: A Pediatric Oncology Group/Children's Cancer Group Intergroup Study. J. Clin. Oncol. 17 (1999) 2137-2143
6. Gobel U., Schneider D.T., Calaminus G., Haas R.J., Schmidt P., and Harms D. Germ-cell tumors in childhood and adolescence. GPOH MAKEI and the MAHO study groups. Ann. Oncol. 11 (2000) 263-271
7. Baranzelli M.C., Bouffet E., Quintana E., Portas M., Thyss A., and Patte C. Non-seminomatous ovarian germ cell tumours in children. Eur. J. Cancer 36 (2000) 376-383
8. Patterson D.M., Murugaesu N., Holden L., Seckl M.J., and Rustin G.J. A review of the close surveillance policy for stage I female germ cell tumors of the ovary and other sites. Int. J. Gynecol. Cancer 18 (2008) 43-50
9. Kumar S., Shah J.P., Bryant C.S., Imudia A.N., Cote M.L., Ali-fehmi R., et al. The prevalence and prognostic impact of lymph node metastasis in malignant germ cell tumors of the ovary. Gynecol. Oncol. 110 (2008) 125-132
10. Lai C.H., Chang T.C., Hsueh S., Wu T.I., Chao A., Chou H.H., et al. Outcome and prognostic factors in ovarian germ cell malignancies. Gynecol. Oncol. 96 (2005) 784-791
11. Murugaesu N., Schmid P., Dancey G., Agarwal R., Holden L., McNeish I., et al. Malignant ovarian germ cell tumors: identification of novel prognostic markers and long-term outcome after multimodality treatment. J. Clin. Oncol. 24 (2006) 4862-4866
12. Billmire D., Vinocur C., Rescorla F., Cushing B., London W., and Schlatter M. Outcome and staging evaluation in malignant germ cell tumors of the ovary in children and adolescents: an intergroup study. J. Pediatr. Surg. 39 (2004) 424-429 discussion 424-9.
13. Smith H.O., Berwick M., Verschraegen C.F., Wiggins C., Lansing L., Muller C.Y., et al. Incidence and survival rates for female malignant germ cell tumors. Obstet. Gynecol. 107 (2006) 1075-1085
14. Nathan H., and Pawlik T.M. Limitations of claims and registry data in surgical oncology research. Ann. Surg. Oncol. 15 (2008) 415-423
15. Giordano S.H., Kuo Y.F., Duan Z., Hortobagyi G.N., Freeman J., and Goodwin J.S. Limits of observational data in determining outcomes from cancer therapy. Cancer 112 (2008) 2456-2466